Oral carcinogenicity study with nickel sulfate hexahydrate in Fischer 344 rats
- PMID: 17692353
- DOI: 10.1016/j.taap.2007.06.024
Oral carcinogenicity study with nickel sulfate hexahydrate in Fischer 344 rats
Abstract
Until now, existing data on the oral carcinogenicity of nickel substances have been inconclusive. Yet, the assessment of oral carcinogenicity of nickel has serious scientific and regulatory implications. In the present study, nickel sulfate hexahydrate was administered daily to Fischer 344 rats by oral gavage for 2 years (104 weeks) at exposure levels of 10, 30 and 50 mg NiSO(4).6H(2)O/kg. This treatment produced a statistically significant reduction in body weight of male and female rats, compared to controls, in an exposure-related fashion at 30 and 50 mg/kg/day. An exposure-dependent increase in mortality was observed in female rats. However, the overall study survival rate (males and females) was at least 25 animals per group (compliant with OECD guidelines) in the treated animals. Daily oral administration of nickel sulfate hexahydrate did not produce an exposure-related increase in any common tumor type or an increase in any rare tumors. One tumor type was statistically increased in a nickel sulfate-treated group compared to the study controls (keratoacanthoma in the 10 mg NiSO(4).6H(2)O/kg/day males), but there was no exposure-response relationship for this common tumor type. This study achieved sufficient toxicity to reach the Maximum Tolerated Dose (MTD) while maintaining a sufficiently high survival rate to allow evaluation for carcinogenicity. The present study indicated that nickel sulfate hexahydrate does not have the potential to cause carcinogenicity by the oral route of exposure in the Fischer 344 rat. Data from this and other studies demonstrate that inhalation is the only route of exposure that might cause concern for cancer in association with nickel exposures.
Similar articles
-
Inhalation carcinogenicity study with nickel metal powder in Wistar rats.Toxicol Appl Pharmacol. 2008 Dec 1;233(2):262-75. doi: 10.1016/j.taap.2008.08.017. Epub 2008 Sep 11. Toxicol Appl Pharmacol. 2008. PMID: 18822311
-
Lack of micronuclei formation in bone marrow of rats after repeated oral exposure to nickel sulfate hexahydrate.Mutat Res. 2007 Jan 10;626(1-2):102-10. doi: 10.1016/j.mrgentox.2006.09.001. Epub 2006 Oct 18. Mutat Res. 2007. PMID: 17052950
-
Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?Regul Toxicol Pharmacol. 2005 Mar;41(2):128-33. doi: 10.1016/j.yrtph.2004.11.001. Epub 2004 Dec 19. Regul Toxicol Pharmacol. 2005. PMID: 15698536
-
Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.Int J Toxicol. 2008;27 Suppl 1:1-43. doi: 10.1080/10915810802032388. Int J Toxicol. 2008. PMID: 18569160 Review.
-
Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.Regul Toxicol Pharmacol. 2009 Feb;53(1):6-15. doi: 10.1016/j.yrtph.2008.09.005. Epub 2008 Oct 5. Regul Toxicol Pharmacol. 2009. PMID: 18930102 Review.
Cited by
-
Exploring the molecular mechanisms of nickel-induced genotoxicity and carcinogenicity: a literature review.Rev Environ Health. 2011;26(2):81-92. doi: 10.1515/reveh.2011.012. Rev Environ Health. 2011. PMID: 21905451 Free PMC article. Review.
-
Blood nickel and chromium levels in association with smoking and occupational exposure among head and neck cancer patients in Tunisia.Environ Sci Pollut Res Int. 2013 Nov;20(11):8282-94. doi: 10.1007/s11356-013-1466-7. Epub 2013 Apr 28. Environ Sci Pollut Res Int. 2013. PMID: 23625117
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources